Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

By Ernie Mundell HealthDay ReporterTHURSDAY, July 31, 2025 (HealthDay News) — There’s potentially exciting news from a trial ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

The Trump administration is appealing the court order to reinstate grants and says it will fight “divisive DEI” in science.

Plasma samples showed an association between suppressed extracellular vesicles and an increased risk for liver cancer.

Last week, the Fulton County Board of Health used $5.9 million in new grant funding to rehire 14 HIV and AIDS prevention ...

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

The temporary loss of key HIV grants forced organizations to cut hours, furlough workers and delay critical public health initiatives.

GSK Plc reported better-than-expected profit and raised its estimates for revenue at two key divisions in a report that ...